Transaction · 0002064832-26-000314

Lantheus Alpha Therapy, LLC

Lantheus Alpha Therapy, LLC, 10%, reported an open-market or private sale at Perspective Therapeutics, Inc. involving 78145.000000 shares for an estimated $245609.74. Reported holdings after the transaction were 11599194.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code S10%
CATXPerspective Therapeutics, Inc.
Trade date
Aug 31, 2026
Filing date
Sep 04, 2026
View on SEC Insider profile
Estimated value-$245kShares × reported price
Shares traded78.1k$3.14 per share
Holdings after11.5MDirect
% of reported position traded0.67%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 11,677,339 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

CATX price since this filing

Daily closing prices, with the filing date and available return windows
CATX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d -10.2%30d -11.8%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002064832-26-000314
Common Stock
Transaction date
Aug 31, 2026
Filed Sep 04, 2026, 08:58 PM · 4d delay
Shares
78,145 sh
$3.14 per share
Estimated value
-$245k
Computed from shares × price
Holdings after
11,599,194 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership
Filing-only score

+6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector No10% YesOther No
Footnotes & amended
  1. F1

    Effective June 14, 2024, Perspective Therapeutics, Inc. ("CATX") effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form…

  2. F2

    These sales were previously reported in Form 4s filed by Lantheus Holdings, Inc. on September 2, 2026 and September 3, 2026.

  3. F3

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.095 to $3.165, inclusive. The reporting person undertakes to provi…

  4. F4

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.08 to $3.165, inclusive. The reporting person undertakes to provid…

  5. F5

    Represents securities directly held by Lantheus Alpha Therapy, LLC ("Lantheus"), a wholly owned indirect subsidiary of Lantheus Holdings, Inc. ("Lantheus Holdings"). Under SEC rules and regulations, L…

Original filing · 0002064832-26-000314
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

CATX